FluoroPharma Medical, Inc.
OTC: FPMI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Edward L. Lyons Jr.
- Employees
- 4
- Headquarters
- Montclair, United States
- IPO year
- 2011
- Market cap
- $6.9K
- Website
- https://www.fluoropharma.com
Loading FPMI…
Loading profile data…Frequently asked questions about FPMI
What does FluoroPharma Medical, Inc. (FPMI) do?
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imagin...
Where does FPMI trade?
FluoroPharma Medical, Inc. (FPMI) trades on the Other OTC.
What sector is FPMI in?
FluoroPharma Medical, Inc. (FPMI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of FluoroPharma Medical, Inc.?
Edward L. Lyons Jr. is the chief executive officer of FluoroPharma Medical, Inc. (FPMI).
Where is FluoroPharma Medical, Inc. headquartered?
FluoroPharma Medical, Inc. is headquartered in United States.
Does FPMI pay a dividend?
FluoroPharma Medical, Inc. (FPMI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FPMI go public?
FluoroPharma Medical, Inc. (FPMI) completed its initial public offering in 2011.